Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease of unknown cause. IPF has a poor prognosis with a mean survival of 2 to 5 years after diagnosis. The diagnostic process is often complex and demands a multidisciplinary approach. To date, the only curative therapy available is lung transplant. New insights into the pathogenesis of IPF have brought about changes in standard treatment strategies. New drugs have recently become available and have been shown to slow down the decline in pulmonary function considerably and improve survival.

Download full-text PDF

Source

Publication Analysis

Top Keywords

pulmonary fibrosis
8
[idiopathic pulmonary
4
fibrosis insights]
4
insights] idiopathic
4
idiopathic pulmonary
4
fibrosis ipf
4
ipf chronic
4
chronic progressive
4
progressive lung
4
lung disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!